Cargando…
Screening of the novel antimicrobial drug, XF-73, against 2,527 Staphylococcus species clinical isolates
XF-73 (exeporfinium chloride) is a synthetic, di-cationic porphyrin derivative with rapid, potent bactericidal properties and a low propensity for engendering bacterial resistance. It is being developed clinically for the decolonization of Staphylococcus aureus in the nasal cavity to prevent post-op...
Autores principales: | Rhys-Williams, William, Galvin, Helen Marie, Love, William Guy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600368/ https://www.ncbi.nlm.nih.gov/pubmed/37900306 http://dx.doi.org/10.3389/fcimb.2023.1264456 |
Ejemplares similares
-
Antibacterial and Antibiofilm Potency of XF Drugs, Impact of Photodynamic Activation and Synergy With Antibiotics
por: Board-Davies, Emma Louise, et al.
Publicado: (2022) -
Antimicrobial effects of XF drugs against Candida albicans and its biofilms
por: Board-Davies, E. L., et al.
Publicado: (2023) -
Hair cortisol and adiposity in a population‐based sample of 2,527 men and women aged 54 to 87 years
por: Jackson, Sarah E., et al.
Publicado: (2017) -
Exeporfinium chloride (XF-73) nasal gel dosed over 24 hours prior to surgery significantly reduced Staphylococcus aureus nasal carriage in cardiac surgery patients: Safety and efficacy results from a randomized placebo-controlled phase 2 study
por: Mangino, Julie E., et al.
Publicado: (2023) -
Investigating the Transcriptome of Candida albicans in a Dual-Species Staphylococcus aureus Biofilm Model
por: Short, Bryn, et al.
Publicado: (2021)